Promotion of Dr. Fred Yang to Chief Development Officer

April 19, 2016 –Jinan, China –KBP BioSciences announced today that Dr. Fred Yang has been promoted to Chief Development Officer.

Dr. Yang joined KBP BioSciences in August 2015 as Senior Vice President, Medical Affairs. Under his new role, Dr. Yang will report to Dr. Zhenhua Huang, Executive Chairman of KBP BioSciences.

Dr. Yang’s new assignment encompasses medical development of the company’s clinical stage compounds.”I am very delighted to promote Dr. Fred Yang to this new leadership position.”commented Dr. Zhenhua Huang, Executive Chairman of KBP BioSciences. “Dr. Yang’s depth of medical strategies experience and his commitment and coaching capabilities of our young scientists undoubtedly will further accelerate the development of our company.”

Dr. Yang received his M.S. and PhD degree from University of Wisconsin, and B.S. degree from Peking University.   He has had increasing responsibilities in pharmaceutical companies and biotech with end-to-end development/registration experience in US/EU/Japan etc.